Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_assertion description "[The 5-year survival rates were 57% for esophageal cancer patients with HER2 amplification compared with 32% without, but the difference in overall survival was not significant (P�=�.37).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_assertion evidence source_evidence_literature NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_assertion SIO_000772 21267790 NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_assertion wasDerivedFrom befree-20150227 NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_assertion wasGeneratedBy ECO_0000203 NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP378917.RAcl2SrUPVTdo5cTauLGwOyuyc9LGFZ6oTOEC_kEVtptY130_provenance.